JBC Focus on PI3-Kinase with Echelon

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M001932200 on April 14, 2000

J. Biol. Chem., Vol. 275, Issue 26, 19742-19746, June 30, 2000
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
275/26/19742    most recent
M001932200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Saupe, K. W.
Right arrow Articles by Ingwall, J. S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Saupe, K. W.
Right arrow Articles by Ingwall, J. S.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Kinetic, Thermodynamic, and Developmental Consequences of Deleting Creatine Kinase Isoenzymes from the Heart

REACTION KINETICS OF THE CREATINE KINASE ISOENZYMES IN THE INTACT HEART*

Kurt W. SaupeDagger §, Matthias Spindler§, James C. A. Hopkins||, Weiqun Shen**, and Joanne S. Ingwall||DaggerDagger

From the Dagger  Cardiac Muscle Research Laboratory, Boston University School of Medicine, Boston, Massachusetts 02118, the  Medizinische Universitaetsklinik, Josef-Schneider-Strasse 2, 97080 Wuerzburg, Germany, || NMR Laboratory for Physiological Chemistry, Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts 02115, and ** Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, Indiana 46285

Received for publication, March 8, 2000, and in revised form, April 24, 2000

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Creatine kinase (CK) exists as a family of isoenzymes in excitable tissue. We studied isolated perfused hearts from mice lacking genes for either the main muscle isoform of CK (M-CK) or both M-CK and the main mitochondrial isoform (Mt-CK) to determine 1) the biological significance of CK isoenzyme shifts, 2) the necessity of maintaining a high CK reaction rate, and 3) the role of CK isoenzymes in establishing the thermodynamics of ATP hydrolysis. 31P NMR was used to measure [ATP], [PCr], [Pi], [ADP], pH, as well as the unidirectional reaction rate of PCr right-arrow [gamma -P]ATP. Developmental changes in the main fetal isoform of CK (BB-CK) were unaffected by loss of other CK isoenzymes. In hearts lacking both M- and Mt-CK, the rate of ATP synthesis from PCr was only 9% of the rate of ATP synthesis from oxidative phosphorylation demonstrating a lack of any high energy phosphate shuttle. We also found that the intrinsic activities of the BB-CK and the MM-CK isoenzymes were equivalent. Finally, combined loss of M- and Mt-CK (but not loss of only M-CK) prevented the amount of free energy released from ATP hydrolysis from increasing when pyruvate was provided as a substrate for oxidative phosphorylation.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Creatine kinase (CK,1 EC 2.7.3.2) plays a central role in the energetics of excitable cells, catalyzing the transfer of a phosphoryl moiety between creatine and ADP in the reaction PCr + ADP + H+ left-right-arrow ATP + creatine (Keq of 1.66 × 109 mol/l-1). CK exists as a family of five isoenzymes, three dimers located in the cytoplasm (MM, MB, and BB-CK) and two multimers that connect the inner and outer mitochondrial membranes (sarcomeric and ubiquitous Mt-CK). The distribution of these CK isoenzymes is tissue-specific, developmentally regulated, and changes in disease, especially in the heart (1, 2). During development in the heart, BB-CK activity decreases while MM-CK, and later Mt-CK, activities increase. The capacity for ATP synthesis via oxidative phosphorylation also increases during this time. Because the CK reaction is coupled to ATP synthesis, the developmental changes in CK may also be linked to substrate preference for ATP synthesis of the developing heart.

Despite the fact that CK is one of the most abundant enzymes in the heart and plays a central role in the energetics of cardiac muscle, many questions about the biochemistry of CK isoenzymes remain unanswered. Several of these long-standing questions regarding the function of CK isoenzymes in the heart can be directly addressed by studying the hearts from mice bioengineered to lack either the most abundant muscle isoform (MM-CK) or the two most abundant isoforms (MM-CK and Mt-CK).

Here we address four questions central to the role of CK isoenzymes in the heart. The first question is whether a feedback system exists linking changes in the amount of one isoenzyme with a change in the amounts of other isoenzymes. Such a system is suggested by the observations that a reciprocal relationship exists between BB-CK and MM-CK during both development and heart failure (1, 2). The second question is, what are the kinetic properties of each of the CK isoenzymes in the intact beating heart? The properties of the individual isoenzymes determine whether the changes in isoenzyme distribution that occur during development and disease confer a kinetic advantage or disadvantage for maintaining high [ATP]. The third issue is whether the rate of ATP synthesis via the CK reaction can fall below the rate of ATP synthesis from oxidative phosphorylation. It has been suggested that localization of specific CK isoenzymes in the mitochondria and sites of ATP utilization form an "energy shuttle" whereby PCr serves as an efficient energy transfer molecule. Whether this shuttling of phosphoryl moieties is obligatory remains controversial (3-6) but can be directly tested in hearts lacking CK isoenzymes. The fourth issue addressed here is the role of specific CK isoenzymes in determining the thermodynamics of ATP hydrolysis in the heart. It is well established that the amount of free energy released from ATP hydrolysis (Delta GATP) varies in the heart depending on which substrates for oxidative phosphorylation are present (7). What role the CK isoenzymes play in this modulation of Delta GATP is not known.

To address these questions, hearts from wild type mice and mice lacking genes for M-CK (8-10) (MCK-/- mice) or both M-CK and Mt-CK (11, 12) (M/MtCK-/- mice) were studied. In addition to measuring CK isoenzyme distribution and Vmax, 31P NMR spectroscopy was used to measure [ATP], [PCr], [Pi], [ADP], |Delta GATP|, and pH in the isolated, beating hearts. Additionally, the unidirectional flux through the CK reaction (rate of ATP synthesis from PCr or CKvelocity) was measured using 31P magnetization transfer in isolated, beating hearts.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Animals and Experimental Groups-- MCK-/- and M/MtCK-/- mice were provided by Dr. Bè Wieringa, University of Nijmegen, The Netherlands (8, 11). Hearts from fetal (20, 24, and 27 days post-conception), neonatal (1, 3, and 7 days post-partum), young (15 and 25 days post-partum), and adult mice (25-40 weeks of age) were rapidly excised and frozen to define the developmental pattern of change in CK Vmax and CK isoenzyme distribution, confirming the genotype. 185 hearts were studied, 5-15 at each time point for wild type, MCK-/-, and M/MtCK-/-.

Isolated perfused beating hearts from adult mice were studied to measure CKvelocity using 31P magnetization transfer (5 wild type, 5 MCK-/-, and 5 M/MtCK-/-). This group consisted of relatively old mice (60-70 weeks) because they had larger hearts, which improved the signal to noise ratio and provided the sensitivity necessary to detect the very low level of CKvelocity in M/MtCK-/- hearts. A second set of hearts was perfused with glucose as the sole exogenous metabolic substrate (20 wild type, 13 MCK-/-, and 12 M/MtCK) or with both glucose and pyruvate (10 wild type, 10 MCK-/-, and 9 M/MtCK-/-). This group consisted of both male and female mice 25-40 weeks old. For each heart isovolumic contractile function and energetics (using 31P NMR spectroscopy) were measured simultaneously.

The experimental protocols were approved by the Standing Committee on Animals of Harvard Medical Area and followed the recommendations of the National Institutes of Health and American Physiological Society guidelines for the use and care of laboratory animals.

Biochemical Assays-- Total CK activity (CK Vmax) and the amount of activity attributable to each isoenzyme of CK was measured (12, 13). Since 5-10 mg of tissue was needed for this measurement, where necessary, tissue from 3 to 4 fetal hearts was pooled for analysis. CK activities were measured in units of IU per mg of protein and converted to mM/s using the measured concentrations of cardiac protein. All values are expressed as mM/s at 37 °C. To determine whether B-CK (i.e. the monomer peptide) expression is affected by loss of M-CK or the combined loss of M-CK and Mt-CK, direct comparison of the amounts of BB-CK in the three types of hearts is inadequate. Some B-CK monomers exist as MB-CK in wild type hearts, whereas in MCK-/- and M/MtCK-/- hearts, all B-CK is in the form of BB-CK. Therefore, for wild type hearts we calculate the amount of BB-CK that would form if M-CK was not present (0.5 × MB-CK), and we added this to the measured amount of BB-CK.

The myocardial contents of ATP (via high pressure liquid chromatography), creatine (14), and protein (15) were determined in a separate group of freeze-clamped hearts (5 wild type, 5 MCK-/-, and 5 M/MtCK-/-). For ATP, content was converted to concentration using the measured values for protein concentration, which average 0.16 mg of protein/mg wet weight, and the literature value for the ratio of intracellular volume to total cell volume of 0.48 (16). The concentrations of ATP (mM) were 9.6 ± 0.1, 9.4 ± 0.2, and 9.3 ± 0.2 for wild type, MCK-/-, and M/MtCK-/- hearts, respectively (not significant among groups). Total creatine content was 28.2 ± 0.5 mM in wild types, 32.1 ± 0.7 in MCK-/-, and 30.5 ± 0.6 in M/MtCK-/- hearts (not significant among groups). Myocardial oxygen consumption was calculated from the relationship we previously established between rate-pressure-product and myocardial oxygen consumption for wild type, MCK-/-, and M/MtCK-/- hearts (12).

Isolated Perfused Heart Preparation-- Hearts were isolated and perfused in the Langendorff mode (12). The coronary perfusate consisted of phosphate-free Krebs-Henseleit buffer containing (mM) NaCl (118), KCl (5.3), CaCl2 (2.0), MgSO4 (1.2), EDTA (0.5), and NaHCO3 (25), equilibrated with 95% O2 + 5% CO2 yielding a pH of 7.4. Either glucose alone (10) or glucose in combination with pyruvate (0.5) was added as described above. All hearts, except those undergoing magnetization transfer, were paced at 7 Hz.

31P NMR Spectroscopy-- 31P NMR spectra were obtained at 161.94 MHz using a GE-400 wide-bore Omega spectrometer (Freemont, CA) (12). The measured ATP resonance areas/mg wet weight for wild type, MCK-/-, and M/MtCK-/- hearts were not different, averaging 268 ± 11, 250 ± 10, and 282 ± 16, respectively. This confirmed our finding, made using high pressure liquid chromatography, that [ATP] was not different among groups. The ATP resonance area of each heart was used as an internal standard to convert resonance areas of PCr and Pi to their respective concentrations. Intracellular pH was determined by comparing the chemical shift of the Pi and PCr peaks in each spectrum to values from a standard curve.

Cytosolic free [ADP] was calculated using the equilibrium constant of the CK reaction (17) and from values obtained by NMR spectroscopy and biochemical assays (Equation 1),
[<UP>ADP</UP>]=([<UP>ATP</UP>][<UP>free Cr</UP>])<UP>/</UP>([<UP>PCr</UP>][<UP>H<SUP>+</SUP></UP>]K<SUB><UP>eq</UP></SUB>) (Eq. 1)
Keq = 1.66 × 109 mol/liter-1 for a [Mg2+] of 1.0 mM.

For purposes of clarity all values of Delta GATP are expressed as their absolute values as shown in Equation 2,
‖&Dgr;G<SUB><UP>ATP</UP></SUB><UP>‖</UP>(<UP>kJ/mol</UP>)=‖&Dgr;G<SUP>0</SUP>+RT <UP>ln</UP>([<UP>ADP</UP>][<UP>P<SUB>i</SUB></UP>]<UP>/</UP>[<UP>ATP</UP>])<UP>‖</UP> (Eq. 2)
where Delta G0 (-30.5 kJ/mol) is the value of Delta GATP under standard conditions of molarity, temperature, pH, and [Mg2+]; R is the gas constant (8.3 J/mol K), and T is in Kelvin (18).

Magnetization transfer measurement of the forward velocity of the CK reaction, ADP + PCr right-arrow ATP + creatine, was made using the two-site chemical exchange (PCr right-arrow [gamma -31P]ATP) model of Forsen and Hoffmann, providing estimates of the pseudo first-order rate constant (kfor) (19), as modified using a M0Minfinity sequence developed in our laboratory (20). Each of the magnetization transfer spectra consisted of scans accumulated by repetitively cycling through the two different times of presaturation (0 and 4.8 s). The integrated signal intensity of the PCr resonance peak decays from M0 to Minfinity (magnetization at zero and infinite saturation times, respectively) as [gamma -31P]ATP is saturated. kfor was calculated as kfor = (M0 - Minfinity )/(T1 × Minfinity ) using the literature value for T1 of 3.5 s (20). Multiplying the rate constant kfor by the substrate (PCr) concentration yields the forward velocity of the CK reaction, CKvelocity = kfor [PCr]. Acquisition of these spectra required 5 h, during which time contractile function decreased by only 10-20%.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Regulation of CK Isoenzyme Expression during Development-- In wild type hearts CK Vmax increased rapidly from day -7 to day 1 due to an increase in MM-CK (Fig. 1). From day 7 to day 15, CK Vmax continued to increase due to an increase in Mt-CK. In hearts containing only Mt-CK and BB-CK, CK Vmax did not increase prior to day 1; instead, Vmax increased only gradually after day 7 due to an increase in Mt-CK. Although Mt-CK increased after day 7 in these hearts, they had less Mt-CK activity from day 15 through adulthood than wild types (Fig. 1 and Table I). In hearts containing only BB-CK, CK Vmax did not increase after birth. Instead, Vmax gradually decreased. Since all three groups showed the same developmental pattern of change in BB-CK, it is apparent that the post-natal decrease in BB-CK is independent of accumulation of M-CK, Mt-CK, or total CK. Thus, the developmental pattern of change in BB-CK was not affected by deletion of CK isoenzymes nor was the timing of the increase in Mt-CK. However, the magnitude of the increase in Mt-CK was less in hearts lacking MM-CK than in wild types.


View larger version (27K):
[in this window]
[in a new window]
 
Fig. 1.   Top panel, CK Vmax during development in wild type, MCK-/-, and M/MtCK-/- hearts. In wild types the post-partum increase in CK Vmax was due primarily to an increase in the MM-CK isoenzyme. Where S.E. bars cannot be seen, they are within the symbols. Middle panel, Mt-CK activity during development in wild type and MCK-/- hearts. The timing of the post-natal increase in Mt-CK was not affected by loss of MM-CK, but the final amount of Mt-CK was less that in wild types. Bottom panel, BB-CK activity during development in the three types of hearts. Note that neither loss of M-CK nor loss of both M-CK and Mt-CK caused an alteration in the normal developmental pattern of change in BB-CK observed in wild types.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Creatine kinase isoenzyme distribution and activity (Vmax) in adult mouse hearts

In Vivo CK Reaction Velocity (CKvelocity)-- 31P magnetization transfer provides a measure of CK reaction velocity in the intact beating heart. Representative 31P magnetization transfer spectra for hearts containing all CK isoenzymes, only Mt-CK and BB-CK and only BB-CK are shown in Fig. 2. Mean values for kfor and CKvelocity are shown in Table II. The decrease in the PCr resonance area during selective saturation was less in hearts containing only BB-CK and Mt-CK than in wild types, reflecting a decreased rate of ATP synthesis from PCr (CKvelocity) secondary to loss of MM-CK. In hearts containing only BB-CK there was a small but detectable CKvelocity. CKvelocity was 6.2 and 2.9 times the rate of oxidative ATP synthesis in wild type hearts and those lacking MM-CK, respectively. In hearts with only BB-CK, CKvelocity was 9% the rate of oxidative ATP synthesis (Table II).


View larger version (17K):
[in this window]
[in a new window]
 
Fig. 2.   Representative 31P magnetization transfer spectra showing the rate of transfer of a high energy phosphate group between PCr and the gamma -phosphate of ATP. The three spectra on the left are without saturation (M0), and those on the right were obtained with a saturation time of 4.8 s (Minfinity ). In the wild type hearts (top two panels) high energy phosphate transfer is rapid as evidenced by the large decrease in the PCr resonance area during Minfinity . In MCK-/- hearts this rate was much slower as indicated by the modest decrease in the PCr resonance area during Minfinity . In M/MtCK-/- hearts there was a small but detectable transfer of high energy phosphates between PCr and ATP, indicating a very slow rate of CKvelocity. Under base-line conditions (M0) the concentration of PCr is significantly lower in M/MtCK-/- hearts than in the other two groups as reported previously (12).

                              
View this table:
[in this window]
[in a new window]
 
Table II
Relationship between in vivo CK reaction velocity and rate of oxidative ATP synthesis

The values for CKvelocity and CK Vmax for the three types of hearts can be used to calculate the ratio of CKvelocity/CK Vmax for each of the pure isoenzymes (BB-CK, MM-CK, and Mt-CK). For BB-CK this ratio was 0.09, since this was the measured ratio for hearts with only BB-CK. Based on our finding that hearts that were 94% Mt-CK and 6% BB-CK had a CKvelocity/CK Vmax of 0.25, the CKvelocity/CK Vmax of Mt-CK was calculated to be 0.26. By using the values of 0.09 for BB-CK and 0.26 for Mt-CK, we calculated that MM-CK in wild type hearts had a CKvelocity/CK Vmax of 0.10. Thus, BB-CK and MM-CK have the same CKvelocity/CK Vmax, whereas the ratio for Mt-CK is ~2.5 times higher.

Contribution of the Individual CK Isoenzymes to changes in |Delta GATP|-- In wild type hearts, including pyruvate in the perfusate as a substrate for oxidative phosphorylation caused the expected changes in energetics as [PCr] increased, whereas [Pi] and [ADP] decreased, resulting in an increased |Delta GATP| (Table III). In hearts that contained only MtCK and BBCK, including pyruvate in the perfusate affected the thermodynamics of ATP hydrolysis in the same way as wild types. In contrast, hearts that contained only BB-CK failed to increase |Delta GATP| in response to pyruvate. Therefore, the combined loss of MM-CK and Mt-CK (but not loss of only MM-CK) prevented hearts from increasing |Delta GATP| when administered pyruvate as a substrate for oxidative phosphorylation.

                              
View this table:
[in this window]
[in a new window]
 
Table III
Effect of including pyruvate in the coronary perfusate on cardiac energetics


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The main findings of this study were as follows. First, loss of M-CK and loss of both M-CK and Mt-CK had little or no effect on either the normal developmental change in the amount of the remaining isoenzymes or the final amounts present in adult hearts. Second, the CKvelocity/CK Vmax of BB-CK and MM-CK were very similar, which suggests that isoenzyme shifts during development and disease do not confer any obvious kinetic advantage. Third, in hearts containing only BB-CK the rate of CKvelocity was only a small fraction of the rate of ATP synthesis from oxidative phosphorylation, demonstrating that phosphoryl shuttling is not obligatory. Finally, the combined loss of M-CK and Mt-CK, but not loss of only M-CK, prevented hearts from significantly increasing |Delta GATP| when perfused with pyruvate as a substrate for oxidative phosphorylation.

Compensatory Response to Loss of CK Isoenzymes in the Developing and Mature Myocardium-- Expression of the isoenzymes of CK in the heart is developmentally regulated (2). Both the developmental and tissue-specific regulation of CK expression can be explained by cis-acting elements (21). Since the genes for the CK isoenzymes are on different chromosomes, it may also be that trans-acting elements are involved in the coordinated expression of CK isoenzymes. During late fetal and neonatal development, expression of both MM-CK and Mt-CK increases dramatically, whereas BB-CK peaks at birth and then declines (Fig. 1) (2). What triggers and coordinates these changes is largely unknown. One possibility is that a change in the amount of one isoenzyme triggers the appropriate changes in the other isoenzymes. Our data indicate that this is not the case, since loss of either MM-CK or both MM-CK and Mt-CK had no effect on the normal post-partum decrease in BB-CK. Also demonstrating the independence of CK isoenzyme regulation during development is the observation that the timing of post-natal increase in Mt-CK was not affected by loss of MM-CK. However, the magnitude of the increase in Mt-CK was less in hearts lacking MM-CK than wild types for unknown reasons.

This independence of isoenzyme regulation during development is consistent with the finding in adult heart and skeletal muscle that loss of MM-CK does not cause a compensatory increase in Mt-CK (9). Less clear, due to the difficulty in quantifying the small amount of cardiac BB-CK, is whether loss of MM-CK causes an increase in BB-CK (9). Here we demonstrated that no compensatory increase in BB-CK occurred in hearts lacking MM-CK and furthermore that even loss of both MM-CK and Mt-CK did not alter the amount of BB-CK. Overall, our results in the developing and mature myocardium demonstrate that the amount of each CK isoenzyme is influenced surprisingly little, if at all, by changes in the amounts of the other isoenzymes.

CKvelocity Relative to Rate of Oxidative ATP Synthesis-- In the healthy mammalian heart, the rate of ATP turnover via the CK reaction (CKvelocity) is 5-10-fold higher than the net rate of ATP synthesis from glycolysis and oxidative phosphorylation combined. Therefore on average each molecule of ATP synthesized from glycolysis and oxidative phosphorylation is converted back and forth between ATP and PCr many times before it is finally hydrolyzed to ADP and Pi. It has been suggested that this high CKvelocity exists to facilitate movement of phosphoryl moieties from their primary site of synthesis (mitochondria), via the more easily diffusable PCr, to the primary site of hydrolysis (cytosolic ATPases) (3-6).

Here for the first time we were able to measure the low rate of CKvelocity in hearts containing only BB-CK, and we found that the CKvelocity is only 9% of the rate of oxidative ATP synthesis. This means that transport of ATP from the mitochondria to the cytoplasm is accomplished without the use of PCr as an obligatory intermediate in these hearts. The CKvelocity measured in hearts containing only BB-CK, although low compared with wild type hearts, is still adequate to explain our previous finding that M/MtCK-/- hearts can hydrolyze normal amounts of PCr during increased work and have no obvious contractile deficits (12). In that study approximately 4 mM PCr was hydrolyzed in 6 min. This would require a CKvelocity of only 0.01 mM/s, well below the measured value of 0.09 mM/s. A similar situation likely exists in skeletal muscle from MCK-/- mice where PCr was hydrolyzed at a normal rate even though the CKvelocity was immeasurable (8).

Kinetic Properties of Individual CK Isoenzymes in Isolated, Beating Hearts-- The ratio of CKvelocity to CK Vmax indicates how fast the CK reaction is proceeding relative to its maximal capacity and has previously been reported for purified CK isoenzymes in solution (22). In solution, CKvelocity/CK Vmax was 0.15 for MM-CK and 0.30 for Mt-CK. When purified isoenzymes are studied in solution, the CKvelocity/CK Vmax ratio provides information about the intrinsic properties of the proteins and defines substrate control of enzyme velocity. When measured in living tissue, this ratio also reflects the influences of any additional regulatory systems (23). By using results obtained in the present study, we calculate the CKvelocity/CK Vmax for the individual CK isoenzymes in beating hearts. The values we measured for the CK isoenzymes in intact beating hearts are similar to those found for purified enzymes in solution. This suggests that, at least under our perfusion conditions and for hearts containing normal CK substrate concentrations, minimal non-substrate regulation occurs in the heart in vivo and that the reaction rate is primarily under substrate control. Furthermore, the finding that the CKvelocity/CK Vmax of BB-CK (0.09) is no larger that MM-CK (0.10) suggests that the isoenzyme shift toward the fetal pattern of expression during cardiac hypertrophy and heart failure confers no obvious kinetic advantage.

Effect of Changing Metabolic Substrates on |Delta GATP|-- Little is known regarding the mechanism(s) by which altering the availability of substrates for oxidative phosphorylation affects |Delta GATP| (7). It is reasonable to expect that they depend at least in part on an intact CK system since the reaction catalyzed by CK maintains [ATP] high and the concentrations of its hydrolysis products (ADP and Pi) low. Supporting a relationship between CK and |Delta GATP| are data that demonstrated that severe acute inhibition of CK led to a fall in |Delta GATP| (24). Here we report that wild type hearts and hearts containing MM-CK and Mt-CK increased |Delta GATP| in response to supplying pyruvate. In contrast, hearts with only BB-CK failed to increase |Delta GATP| when supplied with pyruvate. These results raise the possibility that substrate-dependent changes in |Delta GATP| may depend on Mt-CK, the isoenzyme primarily responsible for PCr synthesis. Alternatively. it may be that the CKvelocity rate in these hearts is inadequate to maintain [ADP] low and [PCr] high. We are not able to distinguish between these two possibilities.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§ These two authors contributed equally to this work.

Dagger Dagger To whom correspondence should be addressed: NMR Laboratory, 221 Longwood Ave., BLI 247, Boston, MA 02115. Tel.: 617-732-6994; Fax: 617-732-6990; E-mail: jingwall@rics.bwh.harvard.edu.

Published, JBC Papers in Press, April 14, 2000, DOI 10.1074/jbc.M001932200

    ABBREVIATIONS

The abbreviations used are: CK, creatine kinase; MCK-/-, mice lacking M-CK; M/MtCK-/-, mice lacking both M-CK and Mt-CK; Delta GATP, the amount of free energy released from ATP hydrolysis; Pcr, phosphocreatine.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Nascimben, L., Ingwall, J. S., Pauletto, P., Friedrich, J., Gwathmey, J. K., Saks, V., Pessina, A. C., and Allen, P. D. (1996) Circulation 94, 1894-1901
2. Ingwall, J. S., Kramer, M., and Friedman, W. (1980) in Heart Creatine Kinase: The Integration of Isoenzymes for Energy Distribution (Jacobus, W. E. , and Ingwall, J. S., eds) , pp. 9-17, Williams & Wilkins, Baltimore
3. Bessman, S. P., and Carpenter, C. L. (1985) Annu. Rev. Biochem. 54, 831-862
4. Aliev, M. K., and Saks, V. A. (1997) Biophys. J. 73, 428-445
5. Meyer, R. A., Sweeney, H. L., and Kushmerick, M. J. (1984) Am. J. Physiol. 246, C365-C377
6. Wallimann, T., and Eppenberger, H. M. (1985) Cell Muscle Motil. 6, 239-285
7. Balschi, J. A., Shen, H., Madden, M. C., Hai, J. O., Bradley, E. L., Jr., and Wolkowicz, P. E. (1997) J. Mol. Cell. Cardiol. 29, 3123-3133
8. Van Deursen, J., Heerschap, A., Oerlemans, F., Ruitenbeek, W., Jap, P., ter Laak, H., and Wieringa, B. (1993) Cell 74, 621-631
9. Veksler, V. I., Kuznetsov, A. V., Anflous, K., Mateo, P., van Deursen, J., Wieringa, B., and Ventura-Clapier, R. (1995) J. Biol. Chem. 270, 19921-19929
10. Van Dorsten, F. A., Nederhoff, M. G., Nicolay, K., and Van Echteld, C. J. (1998) Am. J. Physiol. 275, H1191-H1199
11. Steeghs, K., Benders, A., Oerlemans, F., de Haan, A., Heerschap, A., Ruitenbeek, W., Jost, C., van Deursen, J., Perryman, B., Pette, D., Bruckwilder, M., Koudijs, J., Jap, P., Veerkamp, J., and Wieringa, B. (1997) Cell 89, 93-103
12. Saupe, K. W., Spindler, M., Tian, R., and Ingwall, J. S. (1998) Circ. Res. 82, 898-907
13. Rosalki, S. B. (1967) J. Lab. Clin. Med. 69, 696-705
14. Kammermeier, H. (1973) Anal. Biochem. 56, 341-345
15. Lowry, O. H., Rosebrough, N. J., Farr, A. L., and Randall, R. J. (1951) J. Biol. Chem. 193, 265-275
16. Polimeni, P. I., and Buraczewski, S. I. (1988) J. Mol. Cell. Cardiol. 20, 15-22
17. Lawson, J. W., and Veech, R. L. (1979) J. Biol. Chem. 254, 6528-6537
18. Gibbs, C. (1985) J. Mol. Cell. Cardiol. 17, 727-731
19. Forsen, S., and Hoffmann, R. A. (1963) J. Chem. Phys. 39, 2892-2901
20. Friedrich, J., Nascimben, L., Liao, R., and Ingwall, J. S. (1993) Magn. Reson. Med. 30, 45-50
21. Qin, W., Khuchua, Z., Cheng, J., Boero, J., Payne, R. M., and Strauss, A. W. (1998) Mol. Cell. Biochem. 184, 153-167
22. Van Dorsten, F. A., Furter, R., Bijkerk, M., Wallimann, T., and Nicolay, K. (1996) Biochim. Biophys. Acta 1274, 59-66
23. Ponticos, M., Lu, Q. L., Morgan, J. E., Hardie, D. G., Partridge, T. A., and Carling, D. (1998) EMBO J. 17, 1688-1699
24. Tian, R., and Ingwall, J. S. (1996) Am. J. Physiol. 270, H1207-H1216


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.
Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Cardiovasc ResHome page
J. S. Ingwall
Energy metabolism in heart failure and remodelling
Cardiovasc Res, November 26, 2008; (2008) cvn301v2.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
I. Pinz, S. E. Ostroy, K. Hoyer, H. Osinska, J. Robbins, J. D. Molkentin, and J. S. Ingwall
Calcineurin-induced energy wasting in a transgenic mouse model of heart failure
Am J Physiol Heart Circ Physiol, March 1, 2008; 294(3): H1459 - H1466.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
H. He, M. M. Javadpour, F. Latif, J. C. Tardiff, and J. S. Ingwall
R-92L and R-92W Mutations in Cardiac Troponin T Lead to Distinct Energetic Phenotypes in Intact Mouse Hearts
Biophys. J., September 1, 2007; 93(5): 1834 - 1844.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
J. N. Weiss, L. Yang, and Z. Qu
Thematic review series: Systems Biology Approaches to Metabolic and Cardiovascular Disorders. Network perspectives of cardiovascular metabolism
J. Lipid Res., November 1, 2006; 47(11): 2355 - 2366.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
C. S. Smith, P. A. Bottomley, S. P. Schulman, G. Gerstenblith, and R. G. Weiss
Altered Creatine Kinase Adenosine Triphosphate Kinetics in Failing Hypertrophied Human Myocardium
Circulation, September 12, 2006; 114(11): 1151 - 1158.
[Abstract] [Full Text] [PDF]


Home page
Biophys. JHome page
S. Cortassa, M. A. Aon, B. O'Rourke, R. Jacques, H.-J. Tseng, E. Marban, and R. L. Winslow
A Computational Model Integrating Electrophysiology, Contraction, and Mitochondrial Bioenergetics in the Ventricular Myocyte
Biophys. J., August 15, 2006; 91(4): 1564 - 1589.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
M. ten Hove, C. A. Lygate, A. Fischer, J. E. Schneider, A. E. Sang, K. Hulbert, L. Sebag-Montefiore, H. Watkins, K. Clarke, D. Isbrandt, et al.
Reduced Inotropic Reserve and Increased Susceptibility to Cardiac Ischemia/Reperfusion Injury in Phosphocreatine-Deficient Guanidinoacetate-N-Methyltransferase-Knockout Mice
Circulation, May 17, 2005; 111(19): 2477 - 2485.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
M. Nahrendorf, M. Spindler, K. Hu, L. Bauer, O. Ritter, P. Nordbeck, T. Quaschning, K.-H. Hiller, J. Wallis, G. Ertl, et al.
Creatine kinase knockout mice show left ventricular hypertrophy and dilatation, but unaltered remodeling post-myocardial infarction
Cardiovasc Res, February 1, 2005; 65(2): 419 - 427.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
P. Coutu and J. M. Metzger
Genetic manipulation of calcium-handling proteins in cardiac myocytes. II. Mathematical modeling studies
Am J Physiol Heart Circ Physiol, February 1, 2005; 288(2): H613 - H631.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Spindler, K. Meyer, H. Stromer, A. Leupold, E. Boehm, H. Wagner, and S. Neubauer
Creatine kinase-deficient hearts exhibit increased susceptibility to ischemia-reperfusion injury and impaired calcium homeostasis
Am J Physiol Heart Circ Physiol, September 1, 2004; 287(3): H1039 - H1045.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. S. Ingwall and R. G. Weiss
Is the Failing Heart Energy Starved?: On Using Chemical Energy to Support Cardiac Function
Circ. Res., July 23, 2004; 95(2): 135 - 145.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
G. M. Pohost and J. R. Forder
From the atomic nucleus to man: Nuclear magnetic resonance spectroscopy, the next horizon in diagnostic cardiology
J. Am. Coll. Cardiol., November 5, 2003; 42(9): 1594 - 1595.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
A. V. Naumova, R. G. Weiss, and V. P. Chacko
Regulation of murine myocardial energy metabolism during adrenergic stress studied by in vivo 31P NMR spectroscopy
Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1976 - H1979.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. Spindler, R. Niebler, H. Remkes, M. Horn, T. Lanz, and S. Neubauer
Mitochondrial creatine kinase is critically necessary for normal myocardial high-energy phosphate metabolism
Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H680 - H687.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. Pucar, P. Bast, R. J. Gumina, L. Lim, C. Drahl, N. Juranic, S. Macura, E. Janssen, B. Wieringa, A. Terzic, et al.
Adenylate kinase AK1 knockout heart: energetics and functional performance under ischemia-reperfusion
Am J Physiol Heart Circ Physiol, August 1, 2002; 283(2): H776 - H782.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
S. J. Park, J. Zhang, Y. Ye, S. Ormaza, P. Liang, A. J. Bank, L. W. Miller, and R. J. Bache
Myocardial creatine kinase expression after left ventricular assist device support
J. Am. Coll. Cardiol., June 5, 2002; 39(11): 1773 - 1779.
[Abstract] [Full Text] [PDF]


Home page
FASEB J.Home page
B. CROZATIER, T. BADOUAL, E. BOEHM, P.-V. ENNEZAT, T. GUENOUN, J. SU, V. VEKSLER, L. HITTINGER, and R. VENTURA-CLAPIER
Role of creatine kinase in cardiac excitation-contraction coupling: studies in creatine kinase-deficient mice
FASEB J, May 1, 2002; 16(7): 653 - 660.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
P. P. Dzeja, E. L. Holmuhamedov, C. Ozcan, D. Pucar, A. Jahangir, and A. Terzic
Mitochondria: Gateway for Cytoprotection
Circ. Res., October 26, 2001; 89(9): 744 - 746.
[Full Text] [PDF]


Home page
Physiol. GenomicsHome page
F. KERNEC, M. UNLU, W. LABEIKOVSKY, J. S. MINDEN, and A. P. KORETSKY
Changes in the mitochondrial proteome from mouse hearts deficient in creatine kinase
Physiol Genomics, July 17, 2001; 6(2): 117 - 128.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Ye, C. Wang, J. Zhang, Y. K. Cho, G. Gong, Y. Murakami, and R. J. Bache
Myocardial creatine kinase kinetics and isoform expression in hearts with severe LV hypertrophy
Am J Physiol Heart Circ Physiol, July 1, 2001; 281(1): H376 - H386.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USA